Director TitleAgeSince
Chairman 53 21/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 52.02M
+0.22%+0.07%-1.90%+8.24% 45.81B
-4.36%-5.66%+338.30%+516.88% 43.91B
-0.32%+4.61%+43.90%+26.98% 44.39B
+0.46%-0.83%+6.38%+73.76% 39.4B
-0.17%-3.22%+10.29%+38.69% 31.26B
+3.30%-5.03% - - 15.75B
-0.65%+5.14%+25.61%+120.17% 17.32B
+1.66%+5.30%+19.25%+34.93% 14.73B
+0.19%-1.77%+80.35%+31.52% 13.03B
Average +0.03%-0.94%+65.27%+106.40% 29.51B
Weighted average by Cap. -0.43%-0.87%+76.30%+125.65%
Logo Genkyotex
GenKyoTex SA is a France-based company involved in the biotechnology sector. The Company focuses on the development of therapies based on selective inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) enzymes, which cause a range of disease processes, such as fibrosis, inflammation, pain processing, cancer development and neurodegeneration. The Company's pipeline includes GKT831, a NOX inhibitor aimed at primary biliary cholangitis (PBC) and fibrosis; GKT771, a NOX inhibitor mainly aimed at inflammatory pain and angiogenesis, and other NOX inhibitors, which target at central nervous system (CNS), hearing loss and oncology.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!